Pleomorphic rhabdomyosarcoma, outcomes of patients with advanced disease treated with systemic agents: Retrospective study from the global pushing ultra-rare sarcomas towards hope (PUSH) consortium.

Saved in:
Bibliographic Details
Title: Pleomorphic rhabdomyosarcoma, outcomes of patients with advanced disease treated with systemic agents: Retrospective study from the global pushing ultra-rare sarcomas towards hope (PUSH) consortium.
Authors: Baldi, Giacomo G.1 (AUTHOR), Giani, Claudia2 (AUTHOR), Ljevar, Silva3 (AUTHOR), Denu, Ryan A.4 (AUTHOR), Napolitano, Andrea5 (AUTHOR), Han, Ilkyu6 (AUTHOR), Brunello, Antonella7 (AUTHOR), Bhadri, Vivek8 (AUTHOR), Sebio, Ana9 (AUTHOR), Andelkovic, Vladimir10 (AUTHOR), Campos, Fernando11 (AUTHOR), Scanferla, Roberto12 (AUTHOR), Abreu, Miguel H.13 (AUTHOR), Desar, Ingrid M.E.14 (AUTHOR), Ogura, Koichi15 (AUTHOR), Wong, Daniel D.16 (AUTHOR), Bae, Susie17 (AUTHOR), Bakhshi, Sameer18 (AUTHOR), Lefler, Daniel S.19 (AUTHOR), Marquina, Gloria20 (AUTHOR)
Source: European Journal of Cancer. May2026, Vol. 238, pN.PAG-N.PAG. 1p.
Database: Academic Search Ultimate
Description
ISSN:09598049
DOI:10.1016/j.ejca.2026.116666